Search Results for "Proxeon Protana"
Original Source: Proxeon Biosystems A/S
Proxeon was incorporated in 2002 under the laws of Denmark and has become a leading provider of proteomics technology as was its predecessor, Protana (which was acquired by MDS Proteomics Inc in 2000).The core competencies of Proxeon are in the areas of mass spectrometry, protein analysis, and the design of hardware and software for proteome analysis. These strengths position Proxeon as a uniquely capable developer of proteomics technology, leading to products that are provided globally to leading research...
Matching Channels
None
Matching News
Transition Therapeutics Announces Fiscal 2012 Year End Financial Results
TORONTO, Sept. 13, 2012 /PRNewswire/ -Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a product-focused biopharmaceutical company developing therapeutics for...
Matching PubMed Articles
None
